Opinion
Video
Author(s):
Drs Safah and Cutler discuss treatment practices for patients with steroid-refractory graft-vs-host disease and highlight patients who are steroid dependent.
Asciminib Bests Standard-of-Care TKIs in Ph+ CML
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
Vanderbilt Symposium Highlights Recent Data on Novel Agents Under Evaluation in Hematologic Malignancies
Revisit the OncLive On Air Episodes From February 2024
Cancer Vaccines Approach New Horizons in Melanoma and Other Solid Tumors
Eckfeldt Looks Towards the Future of AML and MDS Care
Dr Gerds on Updated Data for Pelabresib Plus Ruxolitinib in JAK Inhibitior–Naive Myelofibrosis
Lorlatinib Yields Longest Reported PFS in Advanced NSCLC
Rivoceranib Plus Camrelizumab Maintains Frontline Survival Benefit in Unresectable HCC